These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 18533606

  • 21. [Improvement in glycemic control, cardiovascular risk factors and anthropometric data in type 2 diabetic patients after the switch from biphasic human insulin to biphasic premix analog insulin aspart].
    Gero L, Gyimesi A, Hidvégi T, Jánosi I.
    Orv Hetil; 2009 Aug 30; 150(35):1637-47. PubMed ID: 19692308
    [Abstract] [Full Text] [Related]

  • 22. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R, Lipska KJ, McCoy RG.
    JAMA Intern Med; 2016 Mar 30; 176(3):300-1. PubMed ID: 26882223
    [No Abstract] [Full Text] [Related]

  • 23. [When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs?].
    Stiefelhagen P.
    MMW Fortschr Med; 2011 Jan 13; 153(1-2):14. PubMed ID: 24761480
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy.
    Lopez CA, Kanna B.
    Arch Intern Med; 2008 Mar 10; 168(5):548. PubMed ID: 18332304
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
    Lankisch MR, Del Prato S, Dain MP, Mullins P, Owens DR.
    Prim Care Diabetes; 2016 Feb 10; 10(1):51-9. PubMed ID: 26150328
    [Abstract] [Full Text] [Related]

  • 29. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.
    Ann Intern Med; 2008 Oct 21; 149(8):531-9. PubMed ID: 18936501
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria].
    Jungmann E, Helling T, Jungmann G, Mertens C, Snelting U.
    Fortschr Med Orig; 2001 Jan 11; 118(4):141-6. PubMed ID: 11217677
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr 14; 153(15):44-5. PubMed ID: 21667560
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.